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Abstract  
Purpose  
Home sleep apnea testing (HSAT) has increased due to improvements in technology, accessibility, and changes 
in third party reimbursement requirements. Research studies using HSAT have not consistently reported 
procedures and methodological challenges. This paper had two objectives: (1) summarize the literature on use 
of HSAT in research of adults and (2) identify methodological strategies to use in research and practice to 
standardize HSAT procedures and information.  
Methods  
Search strategy included studies of participants undergoing sleep testing for OSA using HSAT. MEDLINE via 
PubMed, CINAHL, and Embase with the following search terms: “polysomnography,” “home,” “level III,” 
“obstructive sleep apnea,” and “out of center testing.” 
 Results  
Research articles that met inclusion criteria (n = 34) inconsistently reported methods and methodological 
challenges in terms of: (a) participant sampling; (b) instrumentation issues; (c) clinical variables; (d) data 
processing; and (e) patient acceptability. Ten methodological strategies were identified for adoption when using 
HSAT in research and practice.  
Conclusions  
Future studies need to address the methodological challenges summarized in this paper as well as identify and 
report consistent HSAT procedures and information.  
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Introduction  
Obstructive sleep apnea (OSA) in adults has been increasing in prevalence during the last two decades in the 
USA. The increase is attributed in part to the obesity epidemic [1]. Estimates are that moderate to severe OSA, 
defined as an apnea hypopnea index (AHI) ≥ 15, is present in 10% of men ages 30–49 years, 17% of men ages 
50–70 years, and 9% of women ages 50–70 years. OSA contributes significantly to all-cause [2, 3] and cardiac [2] 
mortality. The gold standard for OSA diagnosis is level 1 testing by laboratory polysomnography (PSG). During 
laboratory PSG testing, surface electrodes are positioned to measure electroencephalography, muscle activity, 
heart and respiratory physiology, and ocular movements [4]. This type of testing is recommended in patients 
with co-morbid conditions such as moderate to severe pulmonary disease, neuromuscular disease, congestive 
heart failure, or suspected other sleep disorders (central sleep apnea, periodic limb movement disorder, 
insomnia, parasomnias, circadian rhythm disorders, or narcolepsy) [5]. Because of the increase in OSA 
prevalence, sleep laboratory and diagnostic services are in high demand and alternative methods are needed to 
screen and diagnose sleep disorders.  
In the late 1980s, clinicians began to recognize the need for ambulatory sleep studies and focused on arterial 
oxygen saturation [6]. The first practice parameters for unattended home sleep apnea testing (HSAT) were 
released in 1994 [7] and indications for PSG testing were published in 1997 [8]. At that time, most devices 
measured snoring but did not meet diagnostic requirements for OSA. In 2000, the Agency for Healthcare 
Research and Research Quality (AHRQ) reported results of a meta-analysis that stated broad use of HSAT could 
not be supported due to insufficient evidence [9]. HSAT were further developed to include oxygen saturation, 
heart rate, oral/nasal airflow, respiratory effort, and body position [6]. In 2006, the AASM released a statement 
recommending that physicians who use HSAT need to conduct a clinical assessment and a comprehensive 
patient evaluation. Further, AASM recommended that HSAT could only be used by AASM-accredited sleep 
centers or board-certified sleep physicians and treatment needed to be guided by the evaluation of study results 
and patient symptoms [5, 10]. These recommendations encouraged device manufacturers to develop HSAT that 
met AASM criteria for screening and diagnosis of OSA in home settings. 
 HSAT has increase due to improvements in technology, accessibility, and changes in third party reimbursement 
requirements. HSAT devices also are referred to as home sleep testing (HST), out-of-center sleep testing (OCST), 
portable sleeping monitoring (PSM), and portable monitoring (HSAT) [11]. The Centers for Medicare and 
Medicaid (CMS) released standards for home testing requiring the AHI or respiratory disturbance index (RDI) as 
mandatory for OSA diagnosis by HSAT home testing [12]. AASM created a task force (2007) to develop guidelines 
for HSAT. These guidelines state that the diagnosis of OSA needs to be performed with a comprehensive sleep 
evaluation and with monitors that have level III diagnostic capability, including at least four channels; two 
respiratory variables (respiratory movement and airflow), cardiac measurement (heart rate or 
electrocardiogram), and oxygen saturation. The level III monitors must display raw data and allow for manual 
scoring, or editing of automatic scoring, by a sleep professional because HSAT can underestimate AHI levels 
compared to PSG [5]. HSAT allow patients to have access to a less expensive diagnostic option that can be 
completed in home settings where sleep technologists are not present [13]. Common issues with HSAT include 
missing data due to equipment failure [13, 14] and lower sensitivity and specificity levels compared to PSG [15–
17]. There has been significant night-to-night variability of AHI levels in mild versus moderate OSA when using 
HSAT in home settings [18]. Clinical practice guidelines for diagnostic testing for adult obstructive sleep apnea 
recommend that if a single HSAT is negative, inconclusive, or technically inadequate, a laboratory PSG must be 
performed [19].  
Researchers and clinicians need to be knowledgeable of published literature using level III monitors. Results 
from HSAT can be affected by wear time, accuracy of device application, and scoring methods. A recent study 
showed that when compared to PSG, HSAT with automatic scoring of recording time overestimated the total 
sleep time. [20]. Knowledge from this review will inform the readers regarding methodological challenges that 
are common with the use of the devices. There are two main purposes for this manuscript. The first purpose 
was to summarize the literature of methodological challenges using level III HSAT in research in adult patients. 
The second purpose was to identify methodological strategies to use in research and practice to standardize 
HSAT procedures and information.  
Methods  
A medical librarian collaborated with the authors to conduct a review of the literature. Search strategies focused 
on identifying participants undergoing home sleep testing for obstructive sleep apnea diagnosis using HSAT. The 
following electronic databases were used: CINAHL (Cumulative Index to Nursing and Allied Health Literature), 
MEDLINE via PubMed, and Embase. The parameters established included the years 2000 to 2017. A medical 
librarian assisted with the search using the following terms: “obstructive sleep apnea,” “OSAHS,” 
“Polysomnography,” “home,” “devices,” “sleep disordered breathing,” “sleep monitoring,” “sleep test,” and 
“somnography.” The searches included a combination of database-specific controlled vocabulary: “Sleep Apnea, 
Obstructive”[Mesh], MH “Polysomnography”, and “polysomnography”/exp. To focus on home sleep testing, the 
searches dictated removal of any results which would include “sleep center” or “sleep clinic,” in the title or 
abstract. In addition, the reference lists of included articles were screening for additional relevant citations. 
Articles included in the review met the following inclusion criteria: (a) primary research using HSAT that 
reported methods, results, and findings, (b) Level III HSAT examined, (c) studies with ≥30 participants, and (d) 
published in the English language. Studies were excluded if: (a) pediatric participants were included and (b) 
research was retrospective.  
Search results  
Of the 470 articles retrieved, 436 articles were excluded because inclusion criteria were not met. Relevant 
articles (n = 34) were reviewed by the medical librarian and the first author and were subsequently verified by 
the co-authors.  
Selection of pertinent variables  
The authors reviewed the 34 articles to identify challenges when using HSAT in adult patients in research. These 
challenges were summarized to include; (a) participant sampling; (b) instrumentation issues; (c) clinical 
variables; (d) data processing methods; and (e) patient acceptability. Challenges were selected because they 
were the most common topics described in the 34 articles. Table 1 presents the review of the results from these 
articles organized by these criteria. A summary of the review about each challenge will now be presented.  
Participant sampling  
The sample and study settings were generally homogenous in nature and were conducted in a variety of 
countries. Most of the participants were sleep clinic patients who either had or were suspected of having OSA [n 
= 21, (57%)] (Table 1) [13, 16–18, 21–37]. Fourteen studies included participants who had co-morbidities 
associated with OSA but met criteria for HSAT [14, 16, 38–49]. Slightly less than half of the studies [n = 15, 
(44%)] had a sample size greater than or equal to 100 subjects [13, 22, 23, 28, 33, 35, 36, 38–40, 42, 43, 45, 46, 
50]. Almost one third (n = 11) of the studies in this literature review were conducted in the USA [14, 18, 22, 26, 
27, 29, 31, 34, 38, 39, 46]. Studies were conducted in 10 other countries, including: Argentina [30], Brazil [17, 32, 
36, 41, 42], Canada [13, 16, 24, 25, 33, 40], China [21, 37], Italy [35, 44], Japan [45], Spain [28], Sweden [43, 49], 
Taiwan [47], and Turkey [48].   
Table 1 Summary of methods and methodological challenges included in research of HSAT 










Abdel-Kader et al. 
(2012)  
  X X  
Aurora et al. (2014)    X X  
Boulos et al. (2017)  X X X  
Chen et al. (2009)  X  X X  
Danzi-Soares et al. 
(2012)  
  X   
Dawson et al. (2015)  X  X   
Dingli et al. (2003)  X X X X  
Driver et al. (2011) X X X X  
Gjevre et al. et al. 
(2011)  
X  X X  
Goncalves et al. (2007)    X X X 
Guerrero et al. (2014)  X X X X  
Johansson et al. (2012)     X  
Kuna et al. (2011)  X X  X  
Lettieri et al. (2011)  X X    
Maestri et al. (2011)   X X   
Masa et al. (2011)  X  X X  
Michaelson et al. 
(2006)  
X  X X  
Nakayama-Ashida et 
al.(2007) 
 X X   
Nickerson et al. (2015)   X X  X 
Nigro et al. (2012)  X   X  
Pereira et al. (2013)  X X X X  
Polese et al. (2013)  X X X  X 
Prasad et al. (2016)  X  X X  
Reichert et al. (2003)  X X X   
Santos-Silva et al. 
(2009)  
X  X X  
Senchak et al. (2012)    X  X 
Skomro et al. (2010)  X X X  X 
Su et al. (2004)  X  X X  
Tedschi et al. (2013)  X X X   
Tonelli de Oliveira et 
al. (2009)  
X X X X  
Yeh et al. (2015)   X X   
Yin et al. (2006)  X X X X X 
Yuceege et al. (2013)   X X   
Zou et al. (2006)    X   
 
Instrumentation issues  
There were 14 different HSAT used in the studies. However, three models were used in more than half [n = 18, 
(53%)] of the studies [14, 17, 18, 21–23, 25–27, 30, 32, 33, 37, 39–41, 43, 44, 46]. Eleven HSAT were used in the 
remainder of the studies [13, 16, 24, 28, 29, 34–36, 38, 42, 45, 47–49]. Instrumentation-related details included 
in these studies were level of monitor, model, and manufacturer. More than half [n = 18, (53%)] of the studies 
reported problems with overnight collection of sleep data such as: recordings less than the minimum required 
time [14, 40, 45], lack of air flow recordings [23, 36, 37, 45], nasal cannula tube kinking [24], incomplete pulse 
oximetry [37], battery/download failure [13, 17, 24, 31, 33], poor participant compliance [31, 36, 40, 44], overall 
device failure [35, 45, 47], underestimation of AHI severity compared to PSG [27], or unstated reasons [16, 26, 
48].  
Some studies [n = 8, (25%)] reported engaging the participants in education of the HSATs prior to the release of 
the device for home testing [13, 14, 16, 17, 23, 33, 37, 47]. Understanding HSAT instrumentation issues is critical 
to the reliability of clinical variables. Data collected in a laboratory setting may have an environmental bias due 
to sleep technician supervision; HSAT device failures are more likely to be recognized and corrected.  
Clinical variables  
Clinical variables recorded and reported by automatic HSAT analysis include AHI, RDI, and oxygen desaturation 
index (ODI). AHI is the total number of apneas and hypopneas per hour of sleep. AHI levels range from mild (≥5 
and <15), to moderate (15 ≥ and <30), to severe (≥30) [51–53]. When using HSAT, RDI is calculated as the 
number of apneas and hypopneas divided by total recording time. Hypopnea is defined as a ≥ 3% oxygen 
desaturation from baseline and/or the event is associated with an arousal [52]. ODI is the number of times per 
hour of sleep that the oxygen level in the blood drops by greater or equal to 3% from baseline [54]. 
Respiratory event index (REI) may be used as a surrogate for AHI during manual recording. REI is defined as the 
total number of respiratory events scored times 60 divided by monitoring time. Either AHI or REI must be 
reported when manually scoring HSAT [55].  
AHI, RDI, and/or ODI were reported in 28 studies. The majority [(36%) (n = 14] of studies calculated and 
compared AHI levels from HSAT to PSG [16–18, 21, 23, 25, 28, 31–33, 36–38, 41, 42]. One feasibility study 
collected AHI levels in unattended HSAT [40]. Four studies reported RDI and/or ODI [22, 24, 35, 49]; and two 
studies compared RDI and/or ODI from HSAT to PSG [13, 48]. Many studies [n = 10, (31%)] performed 
psychometric testing of HSATs in the sleep laboratory [17, 21–24, 29, 31, 32, 34, 36].  
Each study had different research questions; however, not all clinical variables were compared to PSG. One 
mixed methods study was completed that required participants to undergo HSAT testing and then a qualitative 
interview to discuss their experience with the device [14]. To test intra-subject variability of HSAT data, a study 
recorded AHI and ODI over two consecutive nights [44]. A similar study examined short-term night-to-night 
variability in AHI and predictors during HSAT [18]. One feasibility study focused on analyzing the HSAT data in 
hospitalized stroke patients [40]. A study compared AHI and RDI levels from HSATs to a device made by another 
manufacturer [39]. In another study, AHI levels from a HSAT were compared to the Berlin Questionnaire and the 
Epworth Sleepiness Scale to demonstrate feasibility in military predeployment assessment [46]. One study asked 
patients to complete two consecutive nights of HSAT testing to obtain RDI levels as well as 2 days of actigraphy 
testing to measure sleep onset [45]. Finally, one study compared AHI levels from a HSAT to acetylcholine 
receptor antibodies in patients with myasthenia gravis to examine predictors for OSA [47]. 
Data processing methods  
According to the AASM, HSAT must allow for the display of raw data for manual scoring or be able to be edited 
by a trained sleep technologist. For diagnostic purposes, review of the raw data must be completed by a 
certified sleep specialist or someone who meets eligibility criteria for the sleep medicine certification exam [5].  
In this review, 20 of the 34 articles (58%) discussed HSAT data scoring methods; however, one article did not 
state whether the data were scored automatically or manually [50]. A few studies [n = 4, (13%)] used physicians 
to manually interpret overnight HSAT data [30, 36, 42, 56]; in two studies (6%), physicians reviewed data after it 
was manually scored by a sleep technician [25, 39]. More commonly, studies used sleep technicians [13, 16, 18, 
24, 32, 39, 40, 57], research personnel [23], employees of HSAT manufacturers [29, 34], or unspecified persons 
[43] to manually score data. Only four studies used automatic scoring techniques to analyze the HSAT data [30, 
34, 37, 58]. 
Patient acceptability  
Six studies (19%) asked participants to evaluate use of HSAT. Five reported on ease of use and comfort of the 
HSAT [14, 17, 33, 37, 46]. Three studies measured sleep quality after using HSAT [33, 37, 42] and three studies 
asked their participants to use sleep diaries [18, 33, 42]. Only one study qualitatively measured how participants 
felt about HSAT in terms of importance of OSA testing, ease of use, comfort, and if the participants understood 
how the monitor worked [14]. When analyzing research studies that used HSAT as a methodological instrument, 
it is important to understand the study’s sampling, instrumentation issues, clinical variables, data processing 
methods, and patient acceptability. These topics are vital considerations when using HSAT in research and 
practice. 
Discussion: methodological strategies for using portable sleep monitors in 
research 
There are many challenges when using HSAT in research. Understanding and addressing the challenges when 
designing a research study is vital to obtaining full sets of data and achieving an accurate analysis of the clinical 
variables. Consistent standards of publishing can lead to easier comparability of results across studies. Clinical 
guidelines for the use of HSAT in the diagnosis of OSA have been established [5] and need to be used as a model 
when designing validation studies. Based on findings from this review, the authors make ten suggestions to use 
to standardize HSAT procedures and information in research reports (see Table 2). The ten suggestions are 
organized into five topics: participant sampling, instrumentation issues, clinical variables, data processing 
methods, and patient acceptability. 
Participant sampling  
Suggestion 1. Consider co-morbid conditions when selecting inclusion/exclusion criteria  
According to the AASM task force, HSAT testing is not appropriate in patients with significant co-morbid 
conditions (moderate to severe pulmonary disease, neuromuscular disease, or congestive heart failure) due to 
the degradation of data accuracy. Likewise, HSAT testing is not recommended in patients suspected of having 
other sleep disorders (central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, circadian 
rhythm disorders, or narcolepsy) [5]. Patients with these comorbid conditions must receive laboratory PSG 
testing under direct supervision of a certified sleep technician in order to establish an OSA diagnosis. 
Suggestion 2. Instruct participant on his/her role in data collection, such as wear time and recordings 
on specific days of the week  
Some participants may be hesitant to engage in research studies that include HSAT because they have busy work 
and life schedules and do not want to experience daytime consequences of wearing the device. Other 
participants may engage in weekend social activities, including alcohol consumption that increase the likelihood 
of pharyngeal collapse and apneic/hypopneic episodes. Consistency in assigning the same days, when feasible, is 
suggested to reduce variability and the length of recording time needed to analyze sleep data. The researcher is 
responsible to explain the importance of adequate wear time to reduce the amount of missing HSAT data. 
Table 2 Methodological strategies to use in research and practice to standardize HSAT procedures and 
information in reports 
• Participant sampling 
1. Consider co-morbid conditions when selecting inclusion/exclusion criteria. 
2. Instruct participants on his/her role in data collection, such as wear time and recordings on specific 
day(s) of the week. 
• Instrumentation issues 
1. Use at least level III HSAT and include a minimum four channels. 
2. Consider cost of HSAT supplies when designing a study. 
• Clinical variables 
1. Report AHI or RDI as the outcome variable from the HSAT. 
2. Provide definition of outcome variable(s). 
• Data processing methods 
1. Determine how HSAT data will be stored, analyzed, and reported when designing the study. 
2. Report the HSAT by model, manufacturer, and use of software. 
• Patient acceptability 
1. Provide HSAT education using return demonstration methods 
2. Provide take-home HSAT education materials that discuss possible technical difficulties and trouble- 
shooting techniques and research assistant contact information. 
Instrumentation issues 
Suggestion 3. Use at least level III HSAT and include a minimum of four channels 
 Portable sleep testing has evolved over time and involves a wide range of available technology. Types of testing 
can range from the most thorough laboratory PSG (level I) which typically records nine physiologic channels 
(electroencephalogram, electrooculogram, electrocardiogram, chin electromyogram (EMG), limb EMG, 
respiratory effort at thorax/abdomen, airflow from nasal cannula, pulse oximetry, and ability to monitor 
continuous positive airway pressure or bi level positive airway pressure) to the least thorough unattended 
portable device, with two channels (oxygen saturation and airflow) [6]. Monitors used in research should be at 
least level III capabilities with minimum of four channels, including two respiratory variables (respiratory 
movement and airflow), cardiac measurement (heart rate or electrocardiogram), and oxygen saturation. Some 
HSAT have features that record snoring, detect light, or can sense changes in body position; however, these 
channels are not mandatory for diagnostic testing [5, 6]. 
Suggestion 4. Consider cost of HSAT supplies when designing a study  
For research purposes, most HSAT are available for rent (policies and cost differ between 
suppliers/companies/models/manufactures). Along with funding for the sleep monitor, researchers must take 
into account the purchase of the sensors that attach to the device, which vary depending on the model (typically 
nasal cannulas, oxygen probes, batteries, abdominal belts). All HSAT used in the research study should be of the 
same type and model to ensure the validity and reliability of the data. 
Clinical variables  
Suggestion 5. Report AHI or RDI as the outcome variable from the HSAT  
Reporting of the AHI or RDI after HSAT is mandatory for OSA diagnosis and reimbursement by Medicare and 
Medicaid standards; ODI may be reported but is not considered diagnostic for OSA [12].  
Suggestion 6. Provide definition(s) of outcome variable(s)  
It is important for researchers to provide clear operational definitions of the variables being measured to 
compare findings and clinical applications. Providing definitions for AHI, RDI, or ODI orients the reader to the 
physiological importance of the data. 
Data processing methods  
Suggestion 7. Determine how HSAT data will be stored, analyzed, and reported when designing the 
study  
Many models of HSAT may be used repeatedly, as the data can be stored, the device cleaned, and released 
quickly to a new participant. One of the challenges is determining how data will be stored after use and 
how/who will analyze it. Prior to beginning the study, researchers need to identify secure places for data storage 
and accessibility according to IRB regulations/ criteria. Once the HSAT data is downloaded and stored in a secure 
area, many manufactures provide programs that allow for automatic or manual scoring. AAMS states that the 
HSAT must display raw data and allow for manual scoring or editing of automatic scoring by a sleep professional 
[5]. Automatic scoring is completed by downloading the HSAT data to the manufacturer’s software program that 
analyzes the data. Manual scoring must take place by a sleep professional who has been trained in scoring raw 
sleep data (sleep technologist or board-certified sleep physician) [5], which can be labor intensive and require 
additional fees for researchers. Measuring and reporting interrater reliability is valuable when using more than 
one professional to manually score in order to assure concordance among raters [59]. 
The researchers must describe methods used for data entry, cleaning of data, and use of statistical software. 
Data analysis methods and the statistical analysis package should be reported to allow for comparisons between 
studies. Psychometric analysis of HSAT should be conducted in comparison to PSG, the gold standard of OSA 
diagnosis. Reporting correlational analyses as well as sensitivity, specificity, positive predictive value, and 
negative predictive value are necessary when conducting validity testing. Percentage of missing data from 
equipment failure, inadequate wear time, or participant refusal must be reported.  
Suggestion 8. Report the HSAT by model, manufacturer, and use of software  
HSAT data recording and analysis may vary between manufacturers. Selecting a HSAT should be based on the 
aims and methodology of the study. It is important to report the specific HSAT model, manufacturer, and 
location, as well as the software used to provide transparency of data collection and analysis methods. 
Patient acceptability 
Suggestion 9. Provide HSAT education using return demonstration methods 
 Participants need to receive in-depth training on the use of the HSAT to obtain complete data. Researchers 
should have a HSAT in their possession for demonstration purposes when participants are being enrolled into a 
study. The participant needs to understand how to use the HSAT prior to enrollment. The researcher should 
demonstrate application of the sensors and the monitor on the participant so they know how the device should 
be worn during sleep. The researcher should request a return demonstration of how to apply the device and the 
how it is turned on and off. Participants should be told to feel free to ask questions about application or 
operation of the device. 
Suggestion 10. Provide take-home HSAT education materials that discuss possible technical difficulties 
and troubleshooting techniques and research assistant contact information 
 Researchers need to be aware of technological difficulties that participants experience once they use the HSAT 
at home. Many manufacturers have developed trouble-shooting and educational handouts that need to be 
given to participants to take home. It is important to provide information on how to contact a research assistant 
with questions when the HSAT is being applied. This will allow participants to contact a staff member with 
questions and to decrease amounts of missing data from insufficient wear time or incorrect application of the 
HSAT. 
Conclusion  
Many methodological challenges accompany the use of HSAT in research and practice. This review examined 
published research literature of HSAT use and strategies used in research. The most consistent strategy 
described in these studies was the reporting of clinical variables. The majority reported AHI and less commonly 
RDI. Data processing was reported in most manuscripts and many used sleep professionals to complete manual 
scoring. The most commonly reported instrumentation issue was device malfunction resulting in loss of data. 
Only one third of the studies included participants who were not enrolled from a sleep clinic. Few studies 
reported using patient acceptability methods. None of the research articles addressed all five topics identified as 
methodological challenges by the authors. 
Sampling needs to be considered when designing studies using HSAT. Participants’ co-morbid conditions need 
be taken into account as well their ability to complete data collection. Understanding the technological 
difficulties that can occur with HSAT, such as device failure or problems with sensor misplacement, is needed 
because data inaccuracies in overnight sleep testing affect the analysis, reliability, and validity of the results, 
especially when compared to PSG. Researchers must determine whether data will be interpreted automatically 
or manually and will need to arrange for a qualified sleep professional to interpret findings accordingly. Finally, 
understanding the patient’s perspective of HSAT is important to achieving complete data. HSAT can be 
perceived as cumbersome to wear during sleep and may cause anxiety for participants if they are not taught and 
involved in interactive teaching how to use the device. 
Ten methodological strategies are suggested for adoption when using HSAT in research and practice. Future 
studies need to address the methodological challenges and identify consistent procedures and reporting using 
these ten suggestions to advance knowledge. The frequency of use of HSAT in the clinical setting has increased 
because of the technological advancement and availability of the devices. Even though laboratory PSG continues 
to be the gold standard of OSA diagnosis, HSAT are used for OSA screening and diagnosis in home settings. The 
body of knowledge regarding HSAT in research is growing rapidly but there has been no report discussing 
methodological strategies for HSAT use in research outside a sleep laboratory. Awareness and action regarding 
these challenges will increase the validity of the data presented in research articles and improve HSAT use in 
clinical practice. 
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